STZ-induced DM rats showed a boosted level of fasting BGL due to the damage of pancreatic β-cells.1,32 The oral administration of WEL and glibenclamide showed an improvement in insulin secretion from existing and regenerated β-cells of the pancreas. The gene discussed is INS; the disease is diabetes mellitus.